I’ve been on winter break for a few days, so have I missed anything essential, as the FDA is being put through the wringer here? So, is the FDA to blame for Faron’s drug study drifting—if not quite completely off course, then at least for its progress slowing down? After all, Europe has its own medicines agency, the EMA, and a registration application can be sent there as well if things go sideways with the FDA.